Institutional & Family Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Institutional & Family Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20	Closed	-$2K	–	912
2019 Q3	$2K	Sell	20 -40	-67%	-$6.07K	﹤0.01%	751
2019 Q2	$10K	Sell	60 -125	-68%	-$21.6K	﹤0.01%	502
2019 Q1	$31K	Buy	+185	New	+$27.5K	0.01%	378
2018 Q3	–	Sell	-200	Closed	-$28K	–	885
2018 Q2	$28K	Buy	+200	New	+$28.4K	0.01%	399

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Institutional & Family Asset Management's GWPH Position: Q4 2019 in Review

Institutional & Family Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 20 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in GWPH in Q2 2018 and held it in 4 quarters. The position peaked at $31K in Q1 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

Institutional & Family Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Institutional & Family Asset Management sold 20 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $2K.
Institutional & Family Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 4 quarters.
Institutional & Family Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $31K in Q1 2019.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Institutional & Family Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.